Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Altman

Showing results (361-370 of 965) with videos related to

Pageof 97
Sort By:
AJNR. American Journal of Neuroradiology|April 16, 2011
Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformationsJ Raymond, O Naggara, F Guilbert, et al.
BMC Medicine|April 19, 2015
Erratum: The National Institutes of Health and guidance for reporting preclinical researchDavid Moher, Marc Avey, Gerd Antes, et al.
Medical Laboratory Sciences|July 1, 1982
Ampicillin and penicillin compared for the treatment of experimental group B streptococcal septicaemia in miceJ R Needham, D G Altman, A G Whitelaw
Journal of General Internal Medicine|November 21, 1998
Statistical reviewing policies of medical journals: caveat lector?S N Goodman, D G Altman, S L George
Plos Medicine|July 22, 2009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementDavid Moher, Alessandro Liberati, Jennifer Tetzlaff, et al.
Plos One|June 15, 2017
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articlesPeggy Sekula, Susan Mallett, Douglas G Altman, et al.
Lancet (London, England)|May 22, 2002
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfallsStuart J Pocock, Tim C Clayton, Douglas G Altman
BMJ Open|August 27, 2013
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional studySally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
Orthodontics & Craniofacial Research|July 19, 2005
Bioreactor cultivation of osteochondral graftsG Vunjak-Novakovic, L Meinel, G Altman, et al.
British Journal of Cancer|July 1, 1994
Quality of life assessment in clinical cancer researchM Olschewski, G Schulgen, M Schumacher, et al.
Pageof 97

Showing results (361-370 of 965) with videos related to

Sort By:
Pageof 97
AJNR. American Journal of Neuroradiology|April 16, 2011
Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformationsJ Raymond, O Naggara, F Guilbert, et al.
BMC Medicine|April 19, 2015
Erratum: The National Institutes of Health and guidance for reporting preclinical researchDavid Moher, Marc Avey, Gerd Antes, et al.
Medical Laboratory Sciences|July 1, 1982
Ampicillin and penicillin compared for the treatment of experimental group B streptococcal septicaemia in miceJ R Needham, D G Altman, A G Whitelaw
Journal of General Internal Medicine|November 21, 1998
Statistical reviewing policies of medical journals: caveat lector?S N Goodman, D G Altman, S L George
Plos Medicine|July 22, 2009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementDavid Moher, Alessandro Liberati, Jennifer Tetzlaff, et al.
Plos One|June 15, 2017
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articlesPeggy Sekula, Susan Mallett, Douglas G Altman, et al.
Lancet (London, England)|May 22, 2002
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfallsStuart J Pocock, Tim C Clayton, Douglas G Altman
BMJ Open|August 27, 2013
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional studySally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
Orthodontics & Craniofacial Research|July 19, 2005
Bioreactor cultivation of osteochondral graftsG Vunjak-Novakovic, L Meinel, G Altman, et al.
British Journal of Cancer|July 1, 1994
Quality of life assessment in clinical cancer researchM Olschewski, G Schulgen, M Schumacher, et al.
Pageof 97